Developing natural product drugs: Supply problems and how they have been overcome

Pharmacology and Therapeutics

Volumn 162, Issue , 2016, Pages 1-9

  Newman, David J ^a  

^a Newman Consulting LLC   (United States)

Author keywords

Complex syntheses; Development; Natural product drugs; Supply problems

Indexed keywords

CARFILZOMIB; EPOXOMICIN; ERIBULIN; HALICHONDRIN B; INGENOL; INGENOL MEBUTATE; NATURAL PRODUCT; TRABECTEDIN; 1,3 DIOXOLANE DERIVATIVE; 3-INGENYL ANGELATE; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; DITERPENE; ETHER DERIVATIVE; FURAN DERIVATIVE; KETONE; MACROLIDE; OLIGOPEPTIDE; TETRAHYDROISOQUINOLINE DERIVATIVE;

AQUACULTURE; ARTICLE; DRUG MANUFACTURE; DRUG USE; EUPHORBIA; EUPHORBIA PEPLUS; METABOLITE; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; UROCHORDATA; ACTINOBACTERIA; ANIMAL; HUMAN; METABOLISM; SPONGE (PORIFERA); SUPPLY AND DISTRIBUTION; SYNTHESIS;

ACTINOBACTERIA; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; DIOXOLES; DITERPENES; ETHERS, CYCLIC; FURANS; HUMANS; KETONES; MACROLIDES; OLIGOPEPTIDES; PORIFERA; TETRAHYDROISOQUINOLINES; UROCHORDATA;

EID: 84951771692     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.12.002     Document Type: Review

References (64)

1. C.M. Abreu, S.L. Price, E.N. Shirk, R.D. Cunha, L.F. Pianowski, J.E. Clements, A. Tanuri, and L. Gama Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo Infection and activation of viral LTR PLoS One 9 2014 e97257
2. T.D. Aicher, K.R. Buszek, F.G. Fang, C.J. Forsyth, S.H. Jung, Y. Kishi, M.C. Matelich, P.M. Scola, D.M. Spero, and S.K. Yoon Total synthesis of halichondrin B and norhalichondrin B J Am Chem Soc 114 1992 3162 3164
3. G. Appendino, G.C. Tron, G. Cravotto, G. Palmisano, and J. Jakupovic An expeditious procedure for the isolation of ingenol from the seeds of Euphorbia lathyris J Nat Prod 62 1999 76 79
4. B.C. Austad, F. Benayoud, T.L. Calkins, S. Campagna, C.E. Chase, H.-W. Choi, W. Christ, R. Costanzo, J. Cutter, A. Endo, F.G. Fang, Y. Hu, B.M. Lewis, M.D. Lewis, S. McKenna, T.A. Noland, J.D. Orr, M. Pesant, M.J. Schnaderbeck, G.D. Wilkie, T. Abe, N. Asai, Y. Asai, A. Kayano, Y. Kimoto, Y. Komatsu, M. Kubota, H. Kuroda, M. Mizuno, T. Nakamura, T. Omae, N. Ozeki, T. Suzuki, T. Takigawa, T. Watanabe, and K. Yoshizawa Process development of Halaven®: Synthesis of the C14-C35 fragment via iterative Nozaki-Hiyama-Kishi reaction-Williamson ether cyclization Synlett 24 2013 327 332
5. B.C. Austad, T.L. Calkins, C.E. Chase, F.G. Fang, T.E. Horstmann, Y. Hu, B.M. Lewis, X. Niu, T.A. Noland, J.D. Orr, M.J. Schnaderbeck, H. Zhang, N. Asakawa, N. Asai, H. Chiba, T. Hasebe, Y. Hoshino, H. Ishizuka, T. Kajima, A. Kayano, Y. Komatsu, M. Kubota, H. Kuroda, M. Miyazawa, K. Tagami, and T. Watanabe Commercial manufacture of Halaven®: chemoselective transformations en route to structurally complex macrocyclic ketones Synlett 24 2013 333 337
6. M. Axelrod, Z. Ou, L.K. Brett, L. Zhang, E.R. Lopez, A.T. Tamayo, V. Gordon, R.J. Ford, M.E. Williams, L.V. Pham, M. Weber, and M.L. Wang Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma Leukemia 28 2014 407 410
7. R.L. Bai, K.D. Paull, C.L. Herald, L. Malspeis, G.R. Pettit, and E. Hamel Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data J Biol Chem 266 1991 15882 15889
8. E.J. Beans, D. Fournogerakis, C. Gauntlett, L.V. Heumann, R. Kramer, M.D. Marsden, D. Murray, T.-W. Chun, J.A. Zack, and P.A. Wender Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo Proc Natl Acad Sci U S A 110 2013 11698 11703
9. R.W. Burg, B.M. Miller, E.E. Baker, J. Birnbaum, S.A. Currie, R. Hartman, Y.L. Kong, R.L. Monaghan, G. Olson, I. Putter, J.B. Tunac, H. Wallick, E.O. Stapley, R. Oiwa, and S. Omura Avermectins, new family of potent anthelmintic agents: producing organism and fermentation Antimicrob Agents Chemother 15 1979 361 367
10. T. Busch, and A. Kirschning Recent advances in the total synthesis of pharmaceutically relevant diterpenes Nat Prod Rep 25 2008 318 341
11. W.C. Campbell, M.H. Fisher, E.O. Stapley, G. Albers-Schönberg, and T.A. Jacob Ivermectin: a potent new antiparasitic agent Science 221 1983 823 828
12. J.C. Chabala, H. Mrozik, R.L. Tolman, P. Eskola, A. Lusi, L.H. Peterson, M.F. Woods, M.H. Fisher, W.C. Campbell, J.R. Egerton, and D.A. Ostlind Ivermectin, a new broad-spectrum antiparasitic agent J Med Chem 23 1980 1134 1136
13. C.E. Chase, F.G. Fang, B.M. Lewis, G.D. Wilkie, M.J. Schnaderbeck, and X. Zhu Process development of Halaven®: synthesis of the C1-C13 Fragment from d-(-)-gulono-1,4-lactone Synlett 24 2013 323 326
14. C. Cuevas, and A. Francesch Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem Nat Prod Rep 26 2009 322 337
15. C. Cuevas, M. Pérez, M.J. Martín, J.L. Chicharro, C. Fernández-Rivas, M. Flores, A. Francesch, P. Gallego, M. Zarzuelo, F. de la Calle, J. García, C. Polanco, I. Rodríguez, and I. Manzanares Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from cyanosafracin B Org Lett 2 2000 2545 2548
16. M.A.R. Duckworth, C.N. Battershill, D.R. Schiel, and P.R. Bergquist Farming sponges for the production of bioactive materials Mem Queensland Mus 44 1999 155 159
17. E.J. Dumdei, J.W. Blunt, M.H.G. Munro, C.N. Battershill, and M.J. Page The whys and whats of sponge chemistry: why chemists extract sponges and what problems does this cause? Y. Watanabe, N. Fusetani, Sponge Sciences. Multidisciplinary Perspectives 1998 Springer Tokyo 353 364
18. N.F. Dybdal-Hargreaves, A.L. Risinger, and S.L. Mooberry Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent Clin Cancer Res 21 2015 2445 2452
19. J.R. Egerton, D.A. Ostlind, L.S. Blair, C.H. Eary, D. Suhayda, S. Cifelli, R.F. Riek, and W.C. Campbell Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component Antimicrob Agents Chemother 15 1979 372 378
20. M. Elofsson, U. Splittgerber, J. Myung, R. Mohan, and C.M. Crews Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α′, β′-epoxyketones Chem Biol 6 1999 811 822
21. A. Endo, A. Yanagisawa, M. Abe, S. Tohma, T. Kan, and T. Fukuyama Total synthesis of Ecteinascidin 743 J Am Chem Soc 124 2002 6552 6554
22. F.J. Evans, and A.D. Kinghorn A comparative phvtochemical study of the diterpenes of some species of the genera Euphorbia and Elaeophorbia (Euphorbiaceae) Bot J Linn Soc 74 1977 23 35
23. A.C. Green, and G.L. Beardmore Home treatment of skin cancer and solar keratoses Aust J Dermatol 29 1988 127 130
24. B.M. Greene, H.R. Taylor, E.W. Cupp, R.P. Murphy, A.T. White, M.A. Aziz, H. Schulz-Key, S.A. D'Anna, H.S. Newland, L.P. Goldschmidt, C. Auer, A.P. Hanson, S.V. Freeman, E.W. Reber, and P.N. Williams Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis N Engl J Med 313 1985 133 138
25. M. Groll, K.B. Kim, N. Kairies, R. Huber, and C.M. Crews Crystal structure of epoxomicin: 20S proteasome reveals a molecular basis for selectivity of α′, β′-epoxyketone proteasome inhibitors J Am Chem Soc 122 2000 1237 1238
26. B. Han, W. Yao, Y.-T. Oh, J.-S. Tong, S. Li, J. Deng, P. Yue, F.R. Khuri, and S.-Y. Sun The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5 Oncotarget 6 2015 17532 17542
27. M. Hanada, K. Sugawara, K. Kaneta, S. Toda, Y. Nishiyama, K. Tomita, H. Yamamoto, M. Konishi, and T. Oki Epoxomicin, a new antitumor agent of microbial origin J Antibiot 45 1992 1746 1752
28. J.L. Hartwell Plants used against cancer. A survey Lloydia 32 1969 247 296
29. (TM)) Aplidin, and Kahalalide F G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer Agents from Natural Products 1st ed. 2005 Taylor and Francis Boca Raton, FL 215 240
30. Y. Hirata, and D. Uemura Halichondrins - antitumor polyether macrolides from a marine sponge Pure Appl Chem 58 1986 701 710
31. T.G. Holt (PhD Thesis) The isolation and structural characterization of the Ecteinascidins 1986 University of Illinois at Urbana-Champaign
32. J. Hong Natural product synthesis at the interface of chemistry and biology Chem Eur J 20 2014 10204 10212
33. L. Jørgensen, S.J. McKerrall, C.A. Kuttruff, F. Ungeheuer, J. Felding, and P.S. Baran 14-Step synthesis of (+)-Ingenol from (+)-3-Carene Science 341 2013 878 882
34. K.B. Kim, and C.M. Crews From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes Nat Prod Rep 30 2013 600 604
35. A.D. Kinghorn, and F.J. Evans Occurrence of ingenol in Elaeophorbia species Planta Med 26 1974 150 154
36. A.D. Kinghorn, and F.J. Evans A quantitative gas-liquid chromatographic method for phorbol and related diterpenes as their acetates J Pharm Pharmacol 26 1974 408 412
37. L. Li, W. Deng, J. Song, W. Ding, Q.-F. Zhao, C. Peng, W.-W. Song, G.-L. Tang, and W. Liu Characterization of the Saframycin A gene cluster from Streptomyces lavendulae NRRL 11002 revealing a nonribosomal peptide synthetase system for assembling the unusual tetrapeptidyl skeleton in an iterative manner J Bacteriol 190 2008 251 263
38. X. Liang, G. Grue-Sorensen, A.K. Petersen, and T. Hogberg Semisynthesis of ingenol 3-angelate (PEP005): efficient stereoconservative angeloylation of alcohols Synlett 23 2012 2647 2652
39. T.J. Maimone, and P.S. Baran Modern synthetic efforts toward biologically active terpenes Nat Chem Biol 3 2007 396 407
40. S.J. McKerrall, L. Jørgensen, C.A. Kuttruff, F. Ungeheuer, and P.S. Baran Development of a concise synthesis of (+)-Ingenol J Am Chem Soc 136 2014 5799 5810
41. R. Menchaca, V. Martínez, A. Rodríguez, N. Rodríguez, M. Flores, P. Gallego, I. Manzanares, and C. Cuevas Synthesis of natural ecteinascidins (ET-729, ET-745, ET-759B, ET-736, ET-637, ET-594) from Cyanosafracin B J Org Chem 68 2003 8859 8866
42. N. Micale, K. Scarbaci, V. Troiano, R. Ettari, S. Grasso, and M. Zappala Peptide-based proteasome inhibitors in anticancer drug design Med Res Rev 34 2014 1001 1069
43. Q. Michaudel, Y. Ishihara, and P.S. Baran Academia-Industry symbiosis in organic chemistry Acc Chem Res 48 2015 712 721
44. C. Moss, D.H. Green, B. Perez, A. Velasco, R. Henriquez, and J.D. McKenzie Intracellular bacteria associated with the ascidian Ecteinascidia turbinata: phylogenic and in situ hybridization analysis Mar Biol 143 2003 99 110
45. M.H.G. Munro, J.W. Blunt, E.J. Dumdei, S.J.H. Hickford, R.E. Lill, S. Li, C.N. Battershill, and A.R. Duckworth The discovery and development of marine compounds with pharmaceutical potential J Biotechnol 70 1999 15 25
46. E.A. Ottesen, and W.C. Campbell Ivermectin in human medicine J Antimicrob Chemother 34 1994 195 203
47. A.E. Perez-Matos, W. Rosado, and N.S. Govind Bacterial diversity associated with the Caribbean tunicate Ecteinascidia turbinata Antonie Van Leeuwenhoek 92 2007 155 164
48. J.R. Ramsay, A. Suhrbier, J.H. Aylward, S. Ogbourne, S.-J. Cozzi, M.G. Poulsen, K.C. Baumann, P. Welburn, G.L. Redlich, and P.G. Parsons The sap from Euphorbia peplus is effective against human non-melanoma skin cancers Br J Dermatol 164 2011 633 636
49. C.M. Rath, B. Janto, J. Earl, A. Ahmed, F.Z. Hu, L. Hiller, M. Dahlgren, R. Kreft, F. Yu, J.J. Wolff, H.K. Kweon, M.A. Christiansen, K. Hykansson, R.M. Williams, G.D. Ehrlich, and D.H. Sherman Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743 ACS Chem Biol 6 2011 1244 1256
50. K. Rinehart, T.G. Holt, N.L. Fregeau, J.G. Stroh, P.A. Kiefer, F. Sun, L.H. Li, and D.G. Martin Ecteinascidins 729, 743, 745, 759A, 759B and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata J Org Chem 55 1990 4512 4515
51. A.M. Rizk, F.M. Hammouda, M.M. El Missiry, H.M. Radwan, and F.J. Evans Biologically active diterpene esters from Euphorbia peplus Phytochemistry 24 1985 1605 1606
52. M.D. Sayed, A. Riszk, F.M. Hammouda, M.M. El-Missiry, E.M. Williamson, and F.J. Evans Constituents of Egyptian Euphorbiaceae. IX. Irritant and cytotoxic ingenane esters from Euphorbia paralias L Experientia 36 1980 1206 1207
53. M.M. Schofield, S. Jain, D. Porat, G.J. Dick, and D.H. Sherman Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743 Environ Microbiol 17 2015 3964 3975
54. M.M. Sigel, L.L. Wellham, W. Lichter, L.E. Dudeck, J.L. Gargus, and L.H. Lucas Food-Drugs from the Sea: Proceedings 1969 1970 Marine Technology Society Washington, D. C.
55. N. Sin, K.B. Kim, M. Elofsson, L. Meng, H. Auth, B.H. Kwok, and C.M. Crews Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology Bioorg Med Chem Lett 9 1999 2283 2288
56. I.H. Sutherland, and W.C. Campbell Development, pharmacokinetics and mode of action of ivermectin Acta Leiden 59 1990 161 168
57. B.A. Teicher, and J.E. Tomaszewski Proteasome inhibitors Biochem Pharmacol 96 2015 1 9
58. M. Trindade, L.J. van Zyl, J. Navarro-Fernández, and A.A. Elrazak Targeted metagenomics as a tool to tap into marine natural product diversity for the discovery and production of drug candidates Front Microbiol 6 2015 890
59. A. Velasco, P. Acebo, A. Gomez, C. Schleissner, P. Rodriguez, T. Aparicio, S. Conde, R. Munoz, F. de la Calle, J.L. Garcia, and J.M. Sanchez-Puelles Molecular characterization of the safracin biosynthetic pathway from Pseudomonas fluorescens A2-2: designing new cytotoxic compounds Mol Microbiol 56 2005 144 154
60. D. Weedon, and J. Chick Home treatment of basal cell carcinoma Med J Aust 1 1976 928
61. A.E. Wright, D.A. Forleo, G.P. Gunawardana, S.P. Gunasekera, F.E. Koehn, and O.J. McConnell Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata J Org Chem 55 1990 4508 4512
62. S. Xing, and R.F. Siliciano Targeting HIV latency: pharmacologic strategies toward eradication Drug Discov Today 18 2013 541 551
63. M.J. Yu, W. Zheng, and B.M. Seletsky From micrograms to grams: scale-up synthesis of eribulin mesylate Nat Prod Rep 30 2013 1158 1164
64. TM), a Halichondrin B analogue that prolongs overall survival in patients with metastatic breast cancer J.E. Macor, Ann. Rept. Med. Chem Vol. 46 2011 Elsevier Amsterdam 227 241